[Current views on the mode of action of blood glucose lowering biguanides].
D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D002784:Cholesterol / Q000096:biosynthesis; D004285:Dogs; D004735:Energy Transfer / Q000187:drug effects; D005227:Fatty Acids / Q000096:biosynthesis; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism; D007773:Lactates / Q000096:biosynthesis; D008099:Liver / Q000378:metabolism; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D010101:Oxygen Consumption; D011773:Pyruvates / Q000096:biosynthesis; D051381:Rats; D013045:Species Specificity; D013449:Sulfonamides / Q000494:pharmacology
D001645:Biguanides; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D007328:Insulin; D007773:Lactates; D011773:Pyruvates; D013449:Sulfonamides; D002784:Cholesterol; D005947:Glucose